neoplasm
• mice develop lung adenocarcinoma 8 weeks after adenoviral cre recombinase instillation and exhibit multi-focal tumors
• treatment together with the compound EAI045 (an allosteric tyrosine kinase inhibitor) and cetuximab induces marked tumor shrinkage
|
respiratory system
• mice develop lung adenocarcinoma 8 weeks after adenoviral cre recombinase instillation and exhibit multi-focal tumors
• treatment together with the compound EAI045 (an allosteric tyrosine kinase inhibitor) and cetuximab induces marked tumor shrinkage
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
lung cancer | DOID:1324 |
OMIM:211980 OMIM:608935 OMIM:612571 OMIM:612593 OMIM:614210 |
J:235747 |